Finance

Lists
APLLTD:NSE
Alembic Pharmaceuticals Ltd
864,90 INR
+1,23%
(+10,55) 1D
29-сен., 15:30:01 GMT+5:30  ·   INR
All symbols
SymbolPriceChange% Change
Generating top insights for APLLTD...
Open
853,90 INR
High
868,00 INR
Low
837,50 INR
Mkt. cap
170,01 млд
Avg. vol.
165,82 миң
Volume
457,49 миң
Dividend
1,39%
Quarterly dividend
3,00 INR
Ex-dividend date
2026-ж., 29-июл.
P/E ratio
24,52
52-wk high
998,00 INR
52-wk low
635,80 INR
EPS
35,27 INR
Shares outstanding
188,50 млн
No. of employees
17 миң
Open
853,90 INR
High
868,00 INR
Low
837,50 INR
Mkt. cap
170,01 млд
Avg. vol.
165,82 миң
Volume
457,49 миң
Dividend
1,39%
Quarterly dividend
3,00 INR
Ex-dividend date
2026-ж., 29-июл.
P/E ratio
24,52
52-wk high
998,00 INR
52-wk low
635,80 INR
EPS
35,27 INR
Shares outstanding
188,50 млн
No. of employees
17 миң
About Alembic Pharmaceuticals Ltd
CEO-
Employees17,2 миң
Founded1907
Headquarters-
SectorPharmaceutical industry
Website-
Last report
2026-ж., 4-авг.
Fiscal period
Q1 2027
EPS / Est. (INR)
8,80 INR / 7,79 INR
+13,00%beat
Revenue / Est. (INR)
21,50 млд / 18,97 млд
+13,34%beat
Fiscal Q1 2027 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in INR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in INR
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
19,10 млд
18,76 млд
18,48 млд
21,50 млд
Cost of goods sold
5,16 млд
5,29 млд
6,27 млд
6,20 млд
Cost of revenue
5,16 млд
5,29 млд
6,27 млд
6,20 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,38 млд
4,33 млд
4,39 млд
4,74 млд
Operating expense
11,55 млд
11,34 млд
10,85 млд
12,96 млд
Total operating expenses
16,71 млд
16,63 млд
17,11 млд
19,16 млд
Operating income
2,40 млд
2,13 млд
1,36 млд
2,34 млд
Other non operating income
69,00 млн
154,90 млн
-285,60 млн
149,30 млн
EBT including unusual items
2,24 млд
1,61 млд
1,19 млд
2,22 млд
EBT excluding unusual items
2,24 млд
2,04 млд
1,37 млд
2,22 млд
Income tax expense
400,00 млн
295,40 млн
-829,00 млн
495,00 млн
Effective tax rate
17,88%
18,29%
-69,88%
22,31%
Other operating expenses
6,41 млд
6,21 млд
5,56 млд
7,24 млд
Net income
1,85 млд
1,33 млд
2,03 млд
1,73 млд
Net profit margin
9,67%
7,09%
10,97%
8,05%
Earnings per share
9,40
8,51
11,57
8,80
Interest and investment income
-
-
8,60 млн
-
Interest expense
-242,30 млн
-233,10 млн
-225,60 млн
-276,10 млн
Net interest expenses
-242,30 млн
-233,10 млн
-217,00 млн
-276,10 млн
Depreciation and amortization charges
760,70 млн
801,20 млн
885,90 млн
977,10 млн
EBITDA
3,15 млд
2,78 млд
2,12 млд
3,09 млд
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google колдонмолору